Cargando…

Achievement of Low-Density Lipoprotein Cholesterol Targets in Cardiac Rehabilitation: Impact of the 2019 ESC/EAS Dyslipidaemia Guidelines

In 2019 the European Society of Cardiology (ESC) lowered the target values for low-density lipoprotein cholesterol (LDL-C) from <1.8 mmol/L to <1.4 mmol/L for secondary prevention of cardiovascular disease (CVD). The aim of this study was to determine the clinical impact of the 2019 ESC/EAS dy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haegele, Matthias, Djurdjevic, Aleksandar, Jordan, Fabian, Liu, Yu-Ching, Mildner, Leonie, Frey, Simon, Strebel, Ivo, Clerc, Olivier, Burkard, Thilo, Pfister, Otmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740039/ https://www.ncbi.nlm.nih.gov/pubmed/36498631 http://dx.doi.org/10.3390/jcm11237057

Ejemplares similares

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
por: Allahyari, Ali, et al.
Publicado: (2020)

Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
por: Allahyari, Ali, et al.
Publicado: (2020)

The DA VINCI study: is Ireland achieving ESC/EAS guideline–directed LDL-C goals?
por: Offiah, Gregory, et al.
Publicado: (2022)

Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study
por: Brandts, Julia, et al.
Publicado: (2023)

Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition
por: Martin, Seth S, et al.
Publicado: (2022)

Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?
por: Ibn Elhadj, Zied, et al.
Publicado: (2022)

Dyslipidaemia management in the cardiac rehabilitation clinic of a tertiary referral centre: analysis of the impact of new ESC guidance on LDL-C target achievement
por: McCaughey, Conor, et al.
Publicado: (2022)

Monte Carlo simulations to meet the ESC recommended low-density lipoprotein cholesterol targets
por: Deo, Salil V.
Publicado: (2023)

Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
por: Visser, Jolien, et al.
Publicado: (2022)

Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
por: Yang, Ye Seul, et al.
Publicado: (2020)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

The effects of dyslipidaemia and cholesterol modulation on erythrocyte susceptibility to malaria parasite infection
por: Koch, Marion, et al.
Publicado: (2019)

Rare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal
por: Alves, Ana Catarina, et al.
Publicado: (2023)

Seeding hESCs to achieve optimal colony clonality
por: Wadkin, L. E., et al.
Publicado: (2019)

Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021)

Achieving Secondary Prevention Low-Density Lipoprotein Particle Concentration Goals Using Lipoprotein Cholesterol-Based Data
por: Mathews, Simon C., et al.
Publicado: (2012)

Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial
por: Hagiwara, Nobuhisa, et al.
Publicado: (2017)

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention
por: Seo, Suk Min, et al.
Publicado: (2011)

Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea
por: Kim, Siin, et al.
Publicado: (2020)

ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study
por: Mortensen, Martin Bødtker, et al.
Publicado: (2017)

A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort
por: Santos-Ferreira, Cátia, et al.
Publicado: (2020)

The year in dyslipidaemia 2008 /
Publicado: (2009)

The year in dyslipidaemia 2007
Publicado: (2008)

Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
por: Iyengar, S. S., et al.
Publicado: (2020)

The year in dyslipidaemia : version en español 2009-2010 /
Publicado: (2010)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
por: Vallejo-Vaz, Antonio J., et al.
Publicado: (2022)

Dyslipidaemia in Rheumatological Autoimmune Diseases
por: Toms, Tracey E, et al.
Publicado: (2011)

The year in dyslipidaemia 2005-2006
Publicado: (2006)

Angina due to hypertension and dyslipidaemia
por: Fox, Kim
Publicado: (2019)

Nutraceuticals in Paediatric Patients with Dyslipidaemia
por: Banderali, Giuseppe, et al.
Publicado: (2022)

Fixed Combination for the Treatment of Dyslipidaemia
por: Ferri, Nicola, et al.
Publicado: (2023)

Clinical Outcomes according to the Achievement of Target Low Density Lipoprotein-Cholesterol in Patients with Acute Myocardial Infarction
por: Ahn, Taehoon, et al.
Publicado: (2017)

Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)
por: Raal, Frederick J, et al.
Publicado: (2013)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

The Observation System of EAS Muon Component with the EAS Array and the Muon Spectrometer
por: Tsuji, S
Publicado: (2005)

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol
por: Al-Sabti, Hilal, et al.
Publicado: (2022)

Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)
por: Danchin, Nicolas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v9j53uh570cri50qe6c6ja7v21